What is the recommended dose and frequency of ceftriaxone (Ceftriaxone) for the treatment of typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone Dosing for Typhoid Fever

For typhoid fever, administer ceftriaxone 75-80 mg/kg/day intravenously (maximum 2-4 g/day) once daily for 5-7 days in both adults and children. 1

Standard Dosing Regimen

The recommended approach is 80 mg/kg/day IV once daily for 5-7 days, which represents the most widely validated regimen across multiple studies. 1 This dosing achieves adequate plasma concentrations well above the MIC for Salmonella typhi throughout the 24-hour dosing interval, with mean trough levels of 21.7 mcg/ml maintaining therapeutic efficacy. 2

Pediatric Dosing Specifics

  • Children should receive 75-80 mg/kg/day IV (maximum 2 g/day), administered either once daily or divided every 12 hours. 1, 3
  • The once-daily dosing at approximately 80 mg/kg has demonstrated equivalent efficacy to traditional chloramphenicol therapy with cure rates of 79-100%. 3
  • Ceftriaxone is contraindicated in hyperbilirubinemic neonates due to risk of bilirubin displacement. 1

Adult Dosing

  • Adults typically receive 2-4 g IV once daily for 5-7 days. 1
  • Single high-dose regimens (3-4 g daily) for 1-2 days have shown success in some studies, though 5-7 day courses remain the standard recommendation. 4

Treatment Duration Considerations

A flexible-duration approach is supported: continue therapy until defervescence plus an additional 5 days. 5 This strategy achieved:

  • Mean defervescence time of 5.4 days 5
  • Zero relapses compared to 13% relapse rate with chloramphenicol 5
  • Clinical cure in 100% of patients without complications 5

The traditional 5-7 day fixed duration remains appropriate for most cases, with mean defervescence occurring at 4 days when excluding patients with complicating medical conditions. 6

Clinical Response Monitoring

Expected clinical response timeline:

  • Defervescence typically occurs within 4-5 days of initiating therapy 5, 6
  • Patients with persistent fever beyond 5-7 days should be evaluated for complications or treatment failure 6
  • Blood cultures clear rapidly, with bacteremia resolving within the first few days of treatment 6

Important Caveats

Common pitfalls to avoid:

  • Do not use inadequate duration: courses shorter than 5 days (except in specific high-dose protocols) may increase relapse risk 5
  • Monitor for biliary complications: prolonged high-dose therapy can cause biliary sludging, though this is rare with standard 5-7 day courses 1
  • Ensure adequate dosing in children: underdosing below 75 mg/kg/day may compromise efficacy 3

The pharmacokinetic profile in typhoid fever patients shows adequate drug exposure with once-daily dosing, with elimination half-life of 5.2 hours and 49.7% urinary excretion maintaining therapeutic levels throughout the dosing interval. 2

References

Guideline

Ceftriaxone Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacokinetics of ceftriaxone in patients with typhoid fever.

Antimicrobial agents and chemotherapy, 1994

Research

Ceftriaxone therapy in bacteremic typhoid fever.

Antimicrobial agents and chemotherapy, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.